Skip to main content

Table 1 Patient and tumour characteristics

From: Lymph node yield and tumour subsite are associated with survival in stage I–III colon cancer: results from a national cohort study

n = 13,766

n (%)

Gender

 Male

6694 (48.6)

 Female

7072 (51.4)

Age (years)

 < 65

2011 (14.6)

 65–75

6528 (47.4)

 > 75

5227 (38.0)

Location

 Right

7265 (52.8)

 Left

6501 (47.2)

Location, tumor subsite

 Coecum

2718 (19.7)

 Ascending colon

1859 (13.5)

 Hepatic flexure

993 (7.2)

 Transverse colon

1104 (8.0)

 Splenic flexure

591 (4.3)

 Descending colon

580 (4.2)

 Sigmoid colon

5921 (43.0)

T stage

 pT1

728 (5.3)

 pT2

1566 (11.4)

 pT3

9078 (65.9)

 pT4

2303 (16.7)

 Missing value

91 (0.7)

N stage

 N0

8607 (62.5)

 N1

3232 (23.5)

 N2

1927 (14.0)

Priority of surgery

 Elective

11,918 (86.6)

 Acute

1845 (13.4)

 Missing value

3 (0.0)

Type of surgery

 Open

9683 (70.3)

 Laparoscopic

4080 (29.6)

 Missing value

3 (0.0)

Blood transfusion

 Transfusion

3140 (22.8)

 No transfusion

10,036 ( 72.9)

 Missing value

590 (4.3)

Postoperative anastomotic leak

 No leak

 Leak

 Missing value

12,432 (90.3)

744 (5.4)

590 (4.3)

Total lymph node yield

 Median (quartiles)

15 (11–22)

Lymph node yield

 0–5

1001 (7.3)

 6–11

2938 (21.3)

 12–17

4439 (32.2)

 ≥ 18

5388 (39.1)

ASA score

 ASA I

2673 (20.3)

 ASA II

7280 (55.3)

 ASA III

2981 (22.6)

 ASA IV

233 (1.8)

 Missing value

9 (0.0)

Charlson score

 1

8349 (60.6)

 2

1730 (12.6)

 3

720 (5.2)

 4

2377 (17.3)

 Missing value

590 (4.3)

  1. ASA American Society of Anaesthesiologists